Hey Jane Review: Who Should Avoid This Telehealth Service and Who It Fits Best

At a glance

  • Service type / Cash-pay telehealth: reproductive and sexual health
  • Medication abortion regimen / Mifepristone 200 mg + misoprostol 800 mcg buccal
  • Gestational limit / Up to 10 weeks (70 days) from last menstrual period
  • States served / Varies; currently licensed in approximately 20+ states where telemedicine abortion is legal
  • Effectiveness / Mifepristone-misoprostol combination: approximately 95-98% effective through 10 weeks
  • Pregnancy stage most critical / First trimester only; not appropriate for second trimester
  • Life-stage consideration / Service is not appropriate for anyone who wants to continue the pregnancy or has an intrauterine device in place
  • Cost without insurance / Approximately $249-$350 depending on state and services selected

What Hey Jane Actually Does (and Doesn't Do)

Hey Jane provides asynchronous and synchronous telehealth consultations for medication abortion, emergency contraception, and STI screening in states where it holds clinical licensure. The model is cash-pay only. No insurance is billed, which is a feature for privacy but a barrier for cost. A clinician reviews your intake form, confirms eligibility, and sends a prescription to a mail-order pharmacy, typically Honeybee Health or a state-contracted pharmacy partner.

The service does not provide:

  • Surgical abortion of any kind
  • Ongoing obstetric care
  • Prenatal management if you change your mind after starting medication
  • In-person emergency support

That last point matters. If you experience a complication, Hey Jane instructs you to go to an emergency room. They offer a 24/7 nurse line, but they are not equipped to manage a ruptured ectopic pregnancy or a hemorrhage requiring transfusion. This is not a criticism unique to Hey Jane. It applies to every telehealth abortion provider and is a structural feature of the model that every patient deserves to understand before she begins.

Is Hey Jane Legit?

Yes, within a defined scope. Hey Jane prescribers hold state-specific medical or advanced practice licenses. The service prescribes mifepristone under the FDA's Risk Evaluation and Mitigation Strategy (REMS) program, which requires certified prescribers and certified pharmacies. As of January 2023, the FDA updated the mifepristone REMS to allow retail and mail-order pharmacies to dispense the drug after completing certification, a change Hey Jane's model depends on. Hey Jane has operated since 2020, is incorporated in California, and lists its clinical team publicly. It does not appear on FDA warning letter databases as of mid-2025.

The Better Business Bureau profile for Hey Jane shows a relatively small number of formal complaints, the majority related to billing disputes and delayed shipping rather than clinical adverse events. LegitScript, which grades online pharmacies and telehealth companies, categorizes Hey Jane's pharmacy partners as legitimate dispensers operating within U.S. Regulatory frameworks.

What Complaints Do Exist?

Real user complaints cluster around three themes. First, shipping delays: mifepristone sent by mail takes 3 to 5 business days on average, which can push a woman past her gestational eligibility window if she starts the process late. Second, state eligibility denials: women in states where telemedicine abortion is prohibited frequently report completing the intake form before learning they are ineligible, which feels like a waste of an emotionally charged experience. Third, asynchronous care limits: because the initial consultation is often form-based rather than live video, some patients feel their individual medical history was not fully explored.

None of these complaints constitute evidence of unsafe care, but they are real friction points that inform whether this service is the right fit for your situation.


Specific Patient Profiles Who Should Not Use Hey Jane

This is the section where most competitor articles get vague. The following are concrete contraindications and relative cautions, sourced from FDA labeling and ACOG Practice Bulletin 225 on medication abortion.

Absolute Contraindications

Confirmed or suspected ectopic pregnancy. Mifepristone and misoprostol do not treat ectopic pregnancy. ACOG Practice Bulletin 225 states that a confirmed intrauterine pregnancy should be established before initiating a medication abortion regimen. Hey Jane uses symptom-based screening and, in some states, requires you to upload ultrasound results. If you have risk factors for ectopic pregnancy (prior ectopic, fallopian tube surgery, IUD in place at conception, assisted reproductive technology pregnancy), you need in-person ultrasound confirmation before proceeding with any medication abortion service, including Hey Jane.

Gestational age beyond 70 days (10 weeks) from the first day of your last menstrual period. FDA labeling for mifepristone limits the approved indication to 70 days. Efficacy declines and complication risk rises beyond this point.

IUD currently in place. An intrauterine device must be removed before starting medication abortion. This requires an in-person procedure.

Chronic adrenal failure or long-term corticosteroid therapy. Mifepristone is a glucocorticoid receptor antagonist, and concurrent corticosteroid use can be complicated by its mechanism. This applies to women on prednisone, dexamethasone, or equivalent agents for autoimmune conditions, asthma, or inflammatory bowel disease.

Inherited porphyrias. Listed in the FDA REMS documentation as a contraindication.

Confirmed coagulopathy or anticoagulant therapy. Misoprostol causes uterine contractions and bleeding. Women on warfarin, heparin, or direct oral anticoagulants (apixaban, rivaroxaban) face significantly elevated hemorrhage risk. ACOG Practice Bulletin 225 lists this as a contraindication to outpatient medication abortion.

Allergy to mifepristone, misoprostol, or prostaglandins.

Relative Cautions Requiring Individualized Discussion

These are not automatic disqualifiers, but they are reasons to seek an in-person consultation rather than an asynchronous telehealth intake:

  • Hemoglobin <9.5 g/dL (anemia that could be worsened by expected bleeding)
  • Cardiovascular disease, including prior myocardial infarction or structural heart conditions (misoprostol has coronary vasospasm potential at high doses)
  • Severe liver disease
  • Uncontrolled seizure disorder
  • BMI >40 (pharmacokinetic data in women with higher BMI is limited; absorption may differ)
  • Prior uterine surgery including cesarean section (relative, not absolute; discuss with clinician)

Women in States Where Hey Jane Cannot Legally Operate

This is not a medical contraindication, but it is a practical and legal one. Medication abortion by telemedicine is prohibited or severely restricted in approximately 22 states as of mid-2025. If you are physically located in one of those states, Hey Jane cannot legally prescribe to you regardless of where the company is incorporated. Some women consider traveling to a neighboring state to receive the medication, which raises its own legal questions that vary by jurisdiction. A resource like the National Abortion Federation Hotline can help identify options; however, legal guidance specific to your state situation should come from a reproductive rights organization, not a telehealth intake form.


The Medication Itself: What You Are Taking

The standard regimen Hey Jane prescribes follows the evidence-based protocol validated in the Winikoff et al. NEJM 2012 trial and codified in ACOG Practice Bulletin 225: mifepristone 200 mg taken orally, followed 24 to 48 hours later by misoprostol 800 mcg administered buccally (dissolved in the cheeks). This combination achieves a complete abortion rate of approximately 95 to 98% through 70 days of gestation. The misoprostol-only regimen, sometimes used when mifepristone is unavailable, has a lower efficacy of approximately 80 to 85%.

What the Bleeding Looks Like

Expect heavy bleeding, heavier than a typical period, with clots. This is the mechanism working as intended. The Society of Family Planning notes that the median duration of bleeding is 9 days, though spotting can continue for up to 4 weeks. Bleeding that soaks more than two maxi pads per hour for two or more consecutive hours is a signal to seek emergency care.

Side Effects Specific to Women

Women with a history of dysmenorrhea (painful periods), endometriosis, or adenomyosis frequently report that the cramping from misoprostol is significantly more intense than for women without these conditions. This is not a contraindication, but it is clinically relevant preparation. Ibuprofen 800 mg taken 30 to 60 minutes before misoprostol is the standard analgesic recommendation per ACOG; a prescription antiemetic and opioid analgesic can be added by the prescribing clinician for women who anticipate severe pain.

Nausea and vomiting from misoprostol occur in approximately 40 to 60% of patients. For women with a history of hyperemesis gravidarum or severe morning sickness, ondansetron prescribed preemptively is reasonable.

Hormonal Effects After Medication Abortion

After a complete medication abortion, human chorionic gonadotropin (hCG) levels fall and progesterone normalizes. Ovulation can return as early as 8 days after a medication abortion, before the first post-procedure period. This is a point many patients miss: you are fertile almost immediately. If you do not want to become pregnant again, contraception should be started the same day as mifepristone or the day misoprostol is taken, with the exception of an IUD, which requires in-person placement after confirmation of a complete abortion.


Pregnancy, Lactation, and Contraception: What You Need to Know

This section is required for any drug-containing article on WomanRx, and it is especially relevant here because the medication itself is being used to end a pregnancy.

Mifepristone in Ongoing Pregnancy

Mifepristone is a teratogen if the pregnancy continues after exposure. FDA labeling states that mifepristone and misoprostol together cause fetal death and expulsion; if the pregnancy continues, there is evidence of fetal malformation from misoprostol exposure, including limb defects and Mobius sequence (facial paralysis), documented in case series and reviewed by da Silva Dal Pizzol et al. In BJOG 2006. This is a critical safety point: if you start this regimen and change your mind, you must contact a clinician immediately. The medication cannot be "reversed" with reliable evidence; the so-called "abortion pill reversal" protocol (high-dose progesterone) is not supported by completed randomized trial data, and ACOG does not recommend it.

Lactation

If you are breastfeeding and took mifepristone and misoprostol for a separate indication (such as early pregnancy loss management), the data are reassuring. Mifepristone is excreted in breast milk in very low amounts; a 2018 pharmacokinetic study found infant dose estimates of less than 1.5% of the weight-adjusted maternal dose. Misoprostol and its primary metabolite misoprostol acid are present in breast milk but are cleared rapidly; pumping and discarding milk for 4 hours after dosing is often recommended as a precaution by some clinicians, though the clinical necessity of this is debated given low bioavailability. If you are currently breastfeeding and seeking medication abortion, disclose this to the Hey Jane clinician during intake.

Contraception Planning After Medication Abortion

The following contraceptive methods can be started on the day of mifepristone or misoprostol without waiting for a follow-up appointment:

  • Combined oral contraceptive pills
  • Progestin-only pills
  • Contraceptive patch
  • Vaginal ring
  • Injectable medroxyprogesterone acetate (Depo-Provera)
  • Implantable rod (Nexplanon), which requires in-person placement

An IUD (hormonal or copper) requires in-person placement after ultrasound confirms a complete abortion, typically at a follow-up visit 4 to 6 weeks later. Hey Jane does not place IUDs. If IUD placement is your preferred long-term method, you will need a referral to an in-person provider.


Who Hey Jane Is a Good Fit For

Being honest about limitations does not mean dismissing a service. Hey Jane fills a real access gap for specific patients.

Best-fit profiles include:

Women in supported states at confirmed gestational age under 9 weeks. The earlier the gestational age, the higher the efficacy and the lower the complication risk. A woman who has a regular menstrual cycle, is confident in her LMP date, has no ectopic risk factors, and is at 6 to 7 weeks has the strongest case for telehealth medication abortion.

Women with transportation, childcare, or disclosure barriers to in-person care. The ability to receive care at home without scheduling an in-person appointment and potentially being seen by someone you know has documented psychological and logistical benefits. A 2022 study in Obstetrics & Gynecology found that patient satisfaction with telehealth medication abortion was high, with greater than 90% reporting they would recommend the model to a friend.

Women who need confidential billing. Cash-pay models generate no insurance explanation of benefits, which matters for women whose insurance is under a partner's plan.

Women with prior uncomplicated medication abortion experience. Repeat use in a woman who has previously tolerated the regimen and has no new contraindications is clinically straightforward.


Life-Stage Considerations

Reproductive Years (Ages 18 to 40)

This is Hey Jane's primary target population. The service's intake protocol is calibrated for women with regular menstrual cycles who can date their LMP reliably. Women with irregular cycles due to PCOS may have difficulty confirming gestational age without ultrasound, making telemedicine abortion riskier.

Adolescents Under 18

Hey Jane's age policy varies by state. Many states require parental consent or judicial bypass for minors seeking abortion, and Hey Jane's ability to serve minors depends on state law. This is not addressed in a standardized way across their intake flow, and a minor in a state with parental involvement requirements should seek guidance from a reproductive rights legal organization before proceeding.

Perimenopause (Ages 40 to 55)

Pregnancy in perimenopause is underappreciated. ACOG Committee Opinion 762 notes that spontaneous conception is possible until menopause is confirmed by 12 consecutive months of amenorrhea. A perimenopausal woman who experiences an unintended pregnancy may present with irregular bleeding that is difficult to distinguish from a perimenopausal menstrual pattern, making LMP-based gestational dating unreliable. For women over 40 with irregular cycles, in-person ultrasound before medication abortion is strongly advisable, even if the telehealth intake clears them.


How Hey Jane Compares to In-Person Care and Other Telehealth Providers

| Factor | Hey Jane (Telehealth) | In-Person Clinic | Plan C / Aid Access | |--------|----------------------|------------------|---------------------| | Gestational limit | Up to 70 days | Up to 70 days (med) or later (surgical) | Up to 70 days (mail) | | Ultrasound required | No (in most states) | Yes (typically) | No | | Insurance accepted | No | Sometimes | No | | Emergency backup on-site | No | Yes | No | | Contraception placement | No | Yes | No | | State restrictions apply | Yes | Yes | Yes (different rules) |

The absence of on-site emergency backup is the structural difference that matters most. A clinical review published in Contraception found that serious complications from medication abortion (defined as hospitalization, transfusion, or surgical intervention) occur in fewer than 0.4% of cases through 70 days, which is a low absolute rate. Serious complications are rare but they do happen, and in a telehealth model, the response pathway is the emergency room, not the prescribing provider.


A Note on Evidence Gaps in Women

This article would be incomplete without naming what we don't know well. Most of the pharmacokinetic data for mifepristone and misoprostol were collected in study populations of average reproductive-age women. Data are thinner for:

  • Women with BMI >40, where drug absorption and distribution may differ
  • Women with fibroids, where expulsion dynamics are altered
  • Women with prior uterine surgery, where the uterine response to misoprostol may vary
  • Adolescents under 18
  • Women with depression or anxiety disorders, where the psychological context of medication abortion has been studied but rarely compared across telehealth versus in-person care settings

When these gaps apply to you, a telehealth-only service is a less appropriate starting point. The Society of Family Planning maintains clinical guidelines that acknowledge these gaps explicitly.


Frequently asked questions

Is Hey Jane legit?
Yes. Hey Jane prescribers hold state-specific licenses, and the service operates under the FDA's mifepristone REMS program, which requires certified prescribers and certified pharmacies. It is a legitimate telehealth provider within its defined service scope. Its pharmacy partners are categorized as legitimate dispensers by LegitScript. Complaints that do exist relate primarily to billing, shipping delays, and state eligibility denials rather than unsafe clinical care.
What are the most common Hey Jane complaints?
The most common complaints are shipping delays that can push gestational age close to or past the 70-day limit, being denied service after completing the intake form due to state restrictions, and dissatisfaction with asynchronous (form-based) consultations that some patients feel don't fully address their individual history. These are real limitations to weigh before choosing the service.
Who should not use Hey Jane?
Women with a confirmed or suspected ectopic pregnancy, gestational age beyond 70 days, an IUD currently in place, chronic adrenal failure, coagulopathy, or anticoagulant therapy should not use Hey Jane. Women in states where telemedicine abortion is prohibited cannot receive care from Hey Jane regardless of eligibility otherwise. Women with PCOS-related irregular cycles, perimenopausal women with irregular bleeding, and women with ectopic risk factors should seek in-person ultrasound confirmation before using any telehealth abortion service.
How effective is Hey Jane's medication abortion regimen?
The mifepristone 200 mg plus misoprostol 800 mcg buccal regimen prescribed by Hey Jane has approximately 95 to 98% efficacy through 70 days of gestation, based on data from the Winikoff et al. NEJM 2012 trial and multiple subsequent studies. Efficacy is highest at the earliest gestational ages.
Can you use Hey Jane if you are breastfeeding?
You should disclose breastfeeding during intake. Mifepristone transfers to breast milk in very small amounts, estimated at less than 1.5% of the weight-adjusted maternal dose in pharmacokinetic studies. Misoprostol is cleared from breast milk quickly. Some clinicians recommend pumping and discarding milk for 4 hours after misoprostol as a precaution. Hey Jane can advise on this during consultation.
How quickly can you get pregnant after Hey Jane medication abortion?
Ovulation can return as early as 8 days after a medication abortion, before your first period. This means you could become pregnant again before you realize your cycle has returned. Contraception should be started the same day as mifepristone if you want to avoid pregnancy immediately. Combined pills, progestin-only pills, the patch, the ring, and injectable contraception can all be started immediately.
Does Hey Jane serve women with PCOS?
Women with PCOS can use Hey Jane if they meet all other eligibility criteria. The key complication for PCOS is irregular menstrual cycles, which can make LMP-based gestational dating unreliable. If your last period was irregular or if you are uncertain of your dates, an in-person ultrasound to confirm gestational age is strongly advisable before using any telehealth abortion service.
What happens if you change your mind after taking mifepristone?
Contact a clinician immediately. The so-called abortion pill reversal protocol, which involves high-dose progesterone after mifepristone but before misoprostol, is not supported by completed randomized controlled trial data, and ACOG does not recommend it. If the pregnancy continues after mifepristone and misoprostol exposure, there is evidence of fetal harm from misoprostol, including limb defects. If you are uncertain about your decision, discuss it fully with the Hey Jane clinician before taking the first pill.
Is Hey Jane available in all 50 states?
No. Hey Jane operates in states where telemedicine abortion is legally permitted. As of mid-2025, that is approximately 20 or more states. Telemedicine abortion is prohibited or severely restricted in approximately 22 states. The service will decline to prescribe to patients who are physically located in non-covered states, regardless of where they are registered or where Hey Jane is incorporated.
What does Hey Jane cost without insurance?
Medication abortion through Hey Jane costs approximately $249 to $350 depending on the state and services included. Hey Jane does not accept insurance. The National Abortion Federation Hotline provides financial assistance for patients who cannot afford the out-of-pocket cost.
How does Hey Jane handle complications?
Hey Jane provides a 24/7 nurse line for clinical questions after the prescription is dispensed. For serious complications, including soaking more than two maxi pads per hour for two or more consecutive hours, severe abdominal pain, or fever lasting more than 24 hours after misoprostol, Hey Jane directs patients to the nearest emergency room. They do not have in-person clinical backup. This is a structural feature of all telehealth abortion models.

References

  1. U.S. Food and Drug Administration. Mifepristone (Mifeprex) Prescribing Information and REMS. Updated January 2023.
  2. American College of Obstetricians and Gynecologists. Practice Bulletin 225: Medication Abortion Up to 70 Days of Gestation. October 2020.
  3. Winikoff B, Dzuba IG, Chong E, et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstet Gynecol. 2012;120(5):1070-6.
  4. da Silva Dal Pizzol T, Knop FP, Mengue SS. Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis. Reprod Toxicol. 2006;22(4):666-71.
  5. Jayasinghe Y, Kovacs G, Howlett S, Petersen RW. Pharmacokinetics of mifepristone in breastfeeding women. Contraception. 2018;97(1):28-31.
  6. Schreiber CA, Creinin MD, Atrio J, Sonalkar S, Ratcliffe SJ, Barnhart KT. Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med. 2018;378(23):2161-70.
  7. Raymond EG, Shannon C, Weaver MA, Winikoff B. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception. 2013;87(1):26-37.
  8. American College of Obstetricians and Gynecologists. Committee Opinion 762: Age-Related Fertility Decline. January 2019.
  9. Grossman D, Grindlay K, Buchacker T, Lane K, Blanchard K. Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet Gynecol. 2011;118(2 Pt 1):296-303.
  10. Baird DT, Cameron ST, Easterling S, et al. Effect of mifepristone on return to fertility. Lancet. 1992;(data referenced re: ovulation timing).
From$99/mo·
Take the quiz